SEATTLE, WA--(Marketwire - June 26, 2012) -
| Highlighted Links |
Stratos Product Development |
"Stratos' development expertise, combined with nanoMR's chemistry and research, creates an ideal team to deliver an optimal solution for the market," Jim Macemon, VP of Product Development, nanoMR, said. "We have been impressed with Stratos' depth of engineering expertise, and their extensive portfolio in diagnostic instrument and medical device development has been invaluable to our effort."
With proven benchtop results and research in place, nanoMR came to Stratos with the challenge to develop a cost-effective cassette and processing regimen with an input of up to a 10 milliliter blood sample and output of 50 microliters containing purified DNA. Not only does this require superior product development experience and skill, but also an understanding of the complexities of the chemical and biological processes involved and the challenges of high-volume design, manufacturing and production of fluid-filled cartridges.
In addition to developing the instrument, Stratos is performing product requirements definition, hardware and software design with ISO 13485 design controls, and manufacturing strategy and verification activities with output supporting CE certification for clinical trials in Europe. Read more.
Stratos will showcase its partnership with nanoMR at the AACC Clinical Lab Expo at the Los Angeles Convention Center, July 17-19, 2012 in booth #322.
About Stratos Product Development
At Stratos, we know a cohesive, experienced team of developers can't be built overnight. For 25 years, we've been building a superior ecosystem for innovative product development. Expert industrial designers, researchers, software developers, project managers and electrical, mechanical, manufacturing and quality engineers are here to support your next product development challenge. Our collaborative, cross-discipline approach enables us to reduce time to market, maximize product opportunities and create compelling product solutions for users and unmet needs in the marketplace. We partner with clients worldwide, from startup companies to Fortune 500 corporations.
About nanoMR
Founded in 2007 by researchers from the University of New Mexico, nanoMR is an early-stage life sciences company developing novel diagnostic systems for the rapid isolation of rare cell types, including bacterial and fungal pathogens, directly from blood and other matrices. nanoMR's products use an immunomagnetic capture process that can deliver either viable cells for phenotypic analysis, or extracted DNA for molecular analysis by different DNA-based platforms, including PCR, hybridization and DNA sequencing. The company's first product addresses the blood culture market, demonstrating identification of blood-borne infections in less than two hours, compared with days required for conventional blood-culture-based systems.
MEDIA CONTACT:
Rebecca Dawson
Director, Marketing Communications
Email Contact
(206) 448-1388
www.stratos.com
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati:
